8-K filing — GT Biopharma, Inc. (GTBP)
Filed: 2026-09-25 AccNo: 0001493152-26-044309 Size: 204 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Filings · News reference
GT Biopharma Files Prospectus Related To The Offer Up To 13,502,835 Shares Of Common Stock By Selling Stockholders
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
GT Biopharma shares are trading lower. The company announced IND clearance from the FDA for GTB-5550 in multiple myeloma.
GT Biopharma Announces IND Clearance From FDA For GTB-5550 In Multiple Myeloma
FDA clearance of a new IND for GTB-5550 in multiple myeloma (MM) under an investigator sponsored trial (IST) protocolInitiation of Phase 1 trial in MM patients contingent upon timing and receipt of non-dilutive grant